Assessment of Stress, Depression and Anxiety in Healthcare Caring for Patients With COVID-19
NCT ID: NCT04631497
Last Updated: 2022-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
46 participants
OBSERVATIONAL
2020-07-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Emotional Support and Stress Management in Patients Diagnosed With COVID-19
NCT04482023
Psychological Impairment Due to Covid-19
NCT04368312
Perceived Stress Among ICU Medical Staff During COVID-19 Crisis
NCT04604769
COVID-19 : Stress Within Hospital Workers
NCT05037214
Mental Health of Professionals Working in Pediatric Intensive Care Units During the COVID-19 Pandemic
NCT04846907
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of the study is to assess the occurrence of psychiatric disorders in medical personnel dealing with patients suffering from COVID-19 using various psychological tests.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthcare workers
The study will cover employees of the Intensive Care Unit - nurses and doctors working with patients with COVID-19 infection. Test takers will be over the age of 18 and under the age of 70, female and male.
test
1. Beck's Test
2. Test STAI
3. Test PSS
4. the scale of the fascination with death
5. COPE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
test
1. Beck's Test
2. Test STAI
3. Test PSS
4. the scale of the fascination with death
5. COPE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* not understanding the test questions
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jagiellonian University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tomasz Skladzien
Ph.D. M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tomasz Skladzien, Ph.D. M.D.
Role: PRINCIPAL_INVESTIGATOR
Jagiellonian University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital in Cracow
Krakow, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1072.6120.161.2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.